Alpha-4 beta-2 nicotinic acetylcholine receptor (alpha4beta2 nAChR) (alpha4beta2 nAChR)

The alpha-4 beta-2 (alpha4beta2) nicotinic acetylcholine receptor is the most prevalent high-affinity nicotinic receptor subtype in the mammalian brain, primarily functioning as a pentameric ligand-gated ion channel (Gotti et al., 2006, PMID: 17030136). It is predominantly located on presynaptic terminals and cell bodies within the mesolimbic dopamine system, where it plays a pivotal role in modulating the release of neurotransmitters like dopamine, which is central to the brain's reward and reinforcement pathways (Albuquerque et al., 2009, PMID: 19126755). This receptor subtype is characterized by its exceptionally high affinity for nicotine, making it the primary mediator of nicotine addiction and a key target for smoking cessation therapies such as varenicline (Coe et al., 2005, PMID: 15857119). Beyond addiction, alpha4beta2 receptors are involved in cognitive processes including attention and memory, and their decline is a hallmark of neurodegenerative conditions like Alzheimer's and Parkinson's diseases (Dani & Bertrand, 2007, PMID: 17185537). Pharmacological intervention typically involves agonists or partial agonists to stimulate cholinergic signaling or antagonists to block the effects of exogenous nicotine. Due to its widespread influence on CNS excitability, it remains a significant target for developing treatments for neuropsychiatric disorders, although achieving subtype selectivity remains a therapeutic challenge to minimize peripheral side effects (Taly et al., 2009, PMID: 19561620).

Other names

High-affinity nicotine receptorNeuronal acetylcholine receptor subunit alpha-4/beta-2alpha4beta2 nicotinic receptoralpha4beta2 nAChRHigh-affinity brain nAChR

Agonism, partial agonism, non-competitive antagonism, or positive allosteric modulation of the pentameric ion channel to regulate cation conductance and subsequent neurotransmitter release.